Zhejiang Xinguang Pharmaceutical Co Ltd (300519) — Cash Flow Quality Index
Zhejiang Xinguang Pharmaceutical Co Ltd (300519) has a Cash Flow Quality Index of -0.68x as of June 2025. Operating cash flow of CN¥-5.00 Million is below net income of CN¥7.37 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 300519 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Xinguang Pharmaceutical Co Ltd Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for Zhejiang Xinguang Pharmaceutical Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 300519 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Zhejiang Xinguang Pharmaceutical Co Ltd (2013–2024)
Year-by-year earnings quality comparison for Zhejiang Xinguang Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see market value of Zhejiang Xinguang Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.06x | CN¥53.43 Million | CN¥50.39 Million | ▲ +28.1% |
| 2023 | 0.83x | CN¥53.29 Million | CN¥64.36 Million | ▼ -28.7% |
| 2022 | 1.16x | CN¥126.43 Million | CN¥108.82 Million | ▼ -6.7% |
| 2021 | 1.25x | CN¥142.36 Million | CN¥114.28 Million | ▲ +9.5% |
| 2020 | 1.14x | CN¥112.61 Million | CN¥98.98 Million | ▲ +8.7% |
| 2019 | 1.05x | CN¥98.27 Million | CN¥93.90 Million | ▼ -0.7% |
| 2018 | 1.05x | CN¥92.77 Million | CN¥88.00 Million | ▼ -9.9% |
| 2017 | 1.17x | CN¥124.23 Million | CN¥106.16 Million | ▲ +14.9% |
| 2016 | 1.02x | CN¥121.18 Million | CN¥118.96 Million | ▼ -3.1% |
| 2015 | 1.05x | CN¥124.84 Million | CN¥118.78 Million | ▲ +11.2% |
| 2014 | 0.94x | CN¥99.82 Million | CN¥105.65 Million | ▲ +19.1% |
| 2013 | 0.79x | CN¥57.51 Million | CN¥72.47 Million | — |